Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About CURR Interactive Breakdown Better Bets vs. CURR Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Currenc (CURR)

Market Price (10/31/2025): $2.82 | Market Cap: $131.2 Mil
Sector: Information Technology | Industry: Application Software

Currenc (CURR)

Market Price (10/31/2025): $2.82
Market Cap: $131.2 Mil
Sector: Information Technology
Industry: Application Software

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -30%		  Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -33 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -81%
1 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -49%		  Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 72x
2   Stock price has recently run up significantly
6M Rtn6 month market price return is 104%
3   Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -18%, Rev Chg QQuarterly Revenue Change % is -21%
4   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -36%
5   High stock price volatility
Vol 12M is 266%
0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -30%
1 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -49%
2 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -33 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -81%
3 Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 72x
4 Stock price has recently run up significantly
6M Rtn6 month market price return is 104%
5 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -18%, Rev Chg QQuarterly Revenue Change % is -21%
6 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -36%
7 High stock price volatility
Vol 12M is 266%

Market Valuation & Key Metrics

CURRS&P 500
REVENUE GROWTHVERY POOR
Rev LTM ($ Bil)0.0
Rev Chg Q-20.8%6.4%
Rev Chg LTM-18.1%5.4%
Rev Chg 3Y Avg-18.1%5.3%
PROFITABILITYVERY POOR
Op Inc LTM ($ Bil)-0.0
CFO LTM ($ Bil)0.0
Net Inc LTM ($ Bil)-0.0
Op Mgn LTM-81.0%18.7%
CFO/Rev LTM4.5%20.4%
Net Inc Mgn-102.1%12.8%
VALUATIONVERY HIGH
P/S3.23.2
P/CFO70.415.5
P/FCF83.920.6
P/E-3.123.6
STABILITYVERY GOOD
Debt/Equity0.160.21
Cash/Assets0.650.07

CURR Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The 104.4% change in CURR stock from 5/1/2025 to 10/30/2025 was primarily driven by a 89.1% change in the company's P/S Multiple.

501202510302025Change
Stock Price ($)1.412.89104.38%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)46.4450.208.11%
P/S Multiple1.422.6889.05%
Shares Outstanding (Mil)46.5346.530.00%
Cumulative Contribution104.38%

LTM = Last Twelve Months as of date shown
The 7.0% change in CURR stock from 10/30/2024 to 10/30/2025 was primarily driven by a 0.0% change in the company's Total Revenues ($ Mil).

1030202410302025Change
Stock Price ($)2.702.897.04%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)�50.20�
P/S Multiple�2.68�
Shares Outstanding (Mil)33.9846.53-36.92%
Cumulative Contribution�

LTM = Last Twelve Months as of date shown
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
CURR Return-----61%-8%
Peers Return13%-2%-7%6%52%-19%35%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
CURR Win Rate----33%33% 
Peers Win Rate13%10%5%21%33%48% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
CURR Max Drawdown------80% 
Peers Max Drawdown-5%-4%-8%-1%-4%-34% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ADSK, HIT, BIYA, BLIV, BMR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

CURR has limited trading history. Below is the Information Technology sector ETF (XLK) in its place.

Unique KeyEventXLKS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-34.0%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven51.6%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven278 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-31.5%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven46.0%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven79 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-24.1%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven31.8%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven105 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-53.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven115.3%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1183 days1480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -34.0% during the 2022 Inflation Shock from a high on 12/27/2021. A -34.0% loss requires a 51.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Currenc (CURR)

Better Bets than Currenc (CURR)

 CURRBetter Performance than CURR
MetricValueIndustry (Application Software)
Rev Chg LTM-18.1%ORCL (9.7%), PLTR (38.8%), SAP (9.7%), CRM (8.3%), SHOP (29.0%)
Op Mgn LTM-81.0%ORCL (31.6%), PLTR (16.6%), SAP (26.4%), CRM (21.2%), SHOP (15.3%)
CFO/Rev LTM4.5%ORCL (36.5%), PLTR (50.3%), SAP (20.0%), CRM (33.3%), SHOP (18.3%)
FCF/Rev LTM3.8%PLTR (49.7%), SAP (17.7%), CRM (31.6%), SHOP (18.1%), INTU (32.3%)
Total Yield-31.2%ORCL (2.4%), PLTR (0.2%), SAP (2.3%), CRM (3.2%), SHOP (1.0%)
 CURRBetter Performance than CURR
MetricValueAll Other Sectors
Rev Chg LTM-18.1%GOOGL (13.4%), AMZN (10.9%), META (21.3%), TSLA (-1.6%), JPM (8.2%)
Op Mgn LTM-81.0%GOOGL (32.2%), AMZN (11.4%), META (43.2%), TSLA (5.1%), WMT (4.2%)
CFO/Rev LTM4.5%GOOGL (39.3%), AMZN (18.1%), META (56.8%), TSLA (16.5%), WMT (5.5%)
FCF/Rev LTM3.8%GOOGL (19.1%), META (23.7%), TSLA (7.1%), V (56.8%), MA (49.2%)
Total Yield-31.2%GOOGL (3.9%), AMZN (3.0%), META (3.8%), TSLA (0.4%), JPM (6.6%)
 Best Bets In Information Technology Sector
 CURRVRSN NVDA RMBS QLYS ADBE YOU GEN IDCC DBX KLAC
What You Pay           
P/E-3.227.157.150.724.320.616.527.022.216.139.5
P/EBIT-3.919.649.043.222.716.519.69.917.713.732.4
What You Get           
Rev Chg Q-20.8%7.3%55.6%22.7%10.3%10.7%17.5%30.3%34.5%-1.4%23.6%
Rev Chg LTM-18.1%5.5%71.6%31.0%9.6%10.7%19.8%10.6%21.8%-0.0%23.9%
Rev Chg 3Y Avg�5.2%92.0%17.3%12.5%10.5%35.5%14.8%23.3%4.1%10.4%
FCF/Rev 3Y Avg�57.4%41.3%39.3%39.0%37.7%37.3%35.9%35.1%32.9%31.1%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 24%, alpha of 2.9%, and sharpe of 1.04

Latest Trefis Analyses

Trade Ideas

Select past ideas related to CURR. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Currenc

Financials

CURRADSKHITBIYABLIVBMRMedian
NameCurrenc Autodesk Health I.Baiya In.BeLive Beamr Im. 
Mkt Price2.89300.772.610.303.602.592.75
Mkt Cap0.164.10.1---0.1
Rev LTM416,60527---41
Op Inc LTM-331,5151---1
FCF LTM21,8471---2
FCF 3Y Avg-1,704----1,704
CFO LTM21,9254---4
CFO 3Y Avg-1,775----1,775

Growth & Margins

CURRADSKHITBIYABLIVBMRMedian
NameCurrenc Autodesk Health I.Baiya In.BeLive Beamr Im. 
Rev Chg LTM-18.1%13.8%29.7%---13.8%
Rev Chg 3Y Avg-11.7%----11.7%
Rev Chg Q-20.8%17.1%86.2%---17.1%
QoQ Delta Rev Chg LTM-5.3%4.1%19.3%---4.1%
Op Mgn LTM-81.0%22.9%5.0%---5.0%
Op Mgn 3Y Avg-21.5%----21.5%
QoQ Delta Op Mgn LTM-11.2%0.8%-0.1%----0.1%
CFO/Rev LTM4.5%29.1%13.5%---13.5%
CFO/Rev 3Y Avg-30.7%----30.7%
FCF/Rev LTM3.8%28.0%4.9%---4.9%
FCF/Rev 3Y Avg-29.5%----29.5%

Valuation

CURRADSKHITBIYABLIVBMRMedian
NameCurrenc Autodesk Health I.Baiya In.BeLive Beamr Im. 
Mkt Cap0.164.10.1---0.1
P/S3.39.75.4---5.4
P/EBIT-3.945.373.1---45.3
P/E-3.261.4106.2---61.4
P/CFO72.133.340.2---40.2
Total Yield-31.2%1.6%0.9%---0.9%
Dividend Yield0.0%0.0%0.0%---0.0%
FCF Yield 3Y Avg-3.3%----3.3%
D/E0.20.00.0---0.0
Net D/E-0.30.0-0.1----0.1

Returns

CURRADSKHITBIYABLIVBMRMedian
NameCurrenc Autodesk Health I.Baiya In.BeLive Beamr Im. 
1M Rtn72.0%-5.3%-18.7%-48.0%-1.1%-15.4%-10.3%
3M Rtn60.6%-0.8%26.1%-56.5%36.4%-14.8%12.7%
6M Rtn104.4%10.0%328.6%-93.3%-18.0%5.3%7.6%
12M Rtn7.0%4.1%----20.2%4.1%
3Y Rtn-40.3%----40.3%
1M Excs Rtn71.4%-6.4%-21.8%-50.8%-4.9%-16.7%-11.6%
3M Excs Rtn35.9%-8.1%21.1%-65.8%43.8%-23.6%6.5%
6M Excs Rtn82.6%-11.8%306.8%-115.1%-39.7%-16.5%-14.1%
12M Excs Rtn14.8%-12.2%----41.0%-12.2%
3Y Excs Rtn--37.4%-----37.4%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q1
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20233/31/2023
Filing Date8/5/20255/20/20254/14/202511/19/20248/5/20257/11/20247/11/202411/19/20247/11/2024
Key Financials Quarterly         
Total Revenue91011111113131314
Ebitda-3-3-26-0-0-01-2-0
Operating Income-4-4-9-16-1-1-1-2-2
Net Income-5-5-28-5-4-3-4-4-4
EPS-0.10-0.13-0.70-0.13-0.08-0.09-0.13-0.11-0.10
Key Financials TTM         
Total Revenue TTM414346495053---
Ebitda TTM-33-29-27-0-2-2---
Operating Income TTM-33-30-27-20-6-6---
Net Income TTM-42-41-39-16-15-15---
Growth Rates Quarterly         
Total Revenue Growth-20.8%-23.3%-17.1%-11.6%-20.7%----
EBITDA Growth-3160.8%-1091.1%-4879.3%86.8%78.4%----
Operating Income Growth-221.9%-204.1%-760.0%-588.1%11.9%----
Net Income Growth-22.0%-54.0%-529.4%-29.5%-7.6%----
Margins Quarterly         
EBITDA Margin-39.1%-27.7%-237.0%-2.5%-0.9%-1.8%4.1%-16.4%-3.5%
Operating Income Margin-49.9%-43.0%-78.4%-141.5%-12.3%-10.8%-7.6%-18.2%-11.0%
Net Income Margin-53.4%-46.5%-250.0%-44.1%-34.7%-23.2%-32.9%-30.1%-25.5%
Cash & Debt         
Total Cash61656449-4749--
Total Debt212322230313200
Net Debt / (Cash)-40-43-41-27--16-17--
Cash Flows Quarterly         
FCF from Operations-2-115-10-2-0-4--10
Cash Flows TTM         
FCF from Operations TTM223-16-----
Returns to Shareholders Quarterly         
Dividends000000000
Share Repurchases-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly         
ROIC-39.9%-69.2%-143.4%-209.7%--41.1%-32.4%--
Return on Invested Capital (ROIC) TTM         
ROIC TTM-76.4%-121.2%-113.1%-64.9%--45.4%---

Price Behavior

CURR Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta0.45-4.29-9.030.62-0.210.40
Up Beta-2.50-11.74-8.091.02-0.492.66
Down Beta4.77-1.57-15.491.31-0.160.86
Up Capture-0%-183%-190%-6%-14%-2%
Bmk +ve Days13233574144420
Stock +ve Days9182952104109
Down Capture89%-335%-2350%-52%33%34%
Bmk -ve Days8192952107330
Stock -ve Days11223268137149

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity145,187
Short Interest: % Change Since 9302025-39.4%
Average Daily Volume210,101
Days-to-Cover Short Interest1
Basic Shares Quantity46,527,999
Short % of Basic Shares0.3%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
12/3/2024-2.9%-14.8%-7.6%
SUMMARY STATS   
# Positive000
# Negative111
Median Positive   
Median Negative-2.9%-14.8%-7.6%
Max Positive   
Max Negative-2.9%-14.8%-7.6%

SEC Filings

Expand for More

Report DateFiling DateFiling
630202580520256-K 6/30/2025
3312025520202510-Q 3/31/2025
12312024414202510-K 12/31/2024
93020241119202410-Q 9/30/2024
123120237112024S-4/A 12/31/2023
123120219302022S-4 12/31/2021

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.